MedTrace Logo

Elderly With Locally Advanced Lung Cancer: Deciding Through Geriatric Assessment on the Optimal Treatment Strategy

NCT02284308 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 180

Last updated 2025-07-04

No results posted yet for this study

Summary

There is no detailed information available on benefits and harms of intensified treatment with concurrent RCHT among a subpopulation of elderly patients. Reliable tools are needed to distinguish the subgroup of fit patients from frail patients.

Conditions

Sponsors & Collaborators

  • Dutch Society of Physicians for Pulmonology and Tuberculosis

    collaborator OTHER

  • Erasmus Medical Center

    collaborator OTHER

  • VieCuri Medical Centre

    collaborator OTHER

  • AstraZeneca

    collaborator INDUSTRY

  • Dutch Cancer Society

    collaborator OTHER

  • Maastricht Radiation Oncology

    lead OTHER

Principal Investigators

  • Judith van Loon, MD, PhD · Maastro (radiotherapist)

  • Anne-Marie Dingemans, MD, PhD · Erasmus Medical Center

  • Mariska Janssen-Heijnen, PhD · VieCuri Medical Centre

Eligibility

Min Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-07-31
Primary Completion
2025-01-01
Completion
2029-12-18

Countries

  • Netherlands

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02284308 on ClinicalTrials.gov